Related Experiment Videos
Chorion villus sampling and limb deficiency--cause or coincidence?
1Cambridge University Department of Medical Genetics, Addenbrooke's Hospital, U.K.
Prenatal Diagnosis
|March 24, 1998
Summary
Chorion villus sampling (CVS) may pose a risk for limb defects in newborns, particularly when performed early in pregnancy. The risk of transverse limb deficiency decreases significantly after 11 weeks gestation.
Area of Science:
- Obstetrics and Gynecology
- Prenatal Diagnosis
- Teratology
Background:
- Chorion villus sampling (CVS) is a common first-trimester prenatal diagnostic technique.
- Reports in the early 1990s suggested a potential link between early CVS and limb defects.
- Transverse limb deficiency is a congenital condition affecting limb development.
Purpose of the Study:
- To review the evidence associating Chorion villus sampling (CVS) with transverse limb deficiency.
- To evaluate the relationship between gestational age at CVS and the risk of limb defects.
- To clarify the risk profile of CVS concerning limb development.
Main Methods:
- Literature review of reported cases and studies on CVS and limb defects.
- Analysis of the temporal relationship between CVS timing and limb malformations.
- Risk assessment based on gestational age at the time of the procedure.
Main Results:
- The risk of transverse limb deficiency following CVS diminishes with advancing gestational age.
- Elevated risks (10-20 times background) were observed for CVS performed at or before nine weeks.
- Risks approached background levels (a few-fold above) for CVS performed at 11 weeks and beyond.
Conclusions:
- The association between CVS and transverse limb deficiency appears to be gestational age-dependent.
- Performing CVS later in the first trimester (beyond 11 weeks) may reduce the risk of limb defects.
- The period of limb morphogenesis is critical, with risks extending slightly beyond this developmental stage.